About this episode

The episode discusses the FTC's settlement with CVS Caremark and its implications for plan sponsors and insulin pricing.

In this episode of Healthcare Headlines, Mike and Madison cover the FTC's settlement with CVS Caremark. They'll share the good and the bad, how it impacts insulin pricing, what it means for plan sponsors and more. Check out other podcast episodes at Employee Benefits Podcast | Employers Health . Sign up for our monthly newsletter here . Find additional helpful benefits strategies and resources at Articles | Employers Health

People in this episode

Hosts: Mike, Madison

Topics covered

• FTC settlement
• CVS Caremark
• insulin pricing
• plan sponsors
• healthcare

Keywords

• FTC
• CVS Caremark
• settlement
• insulin pricing
• plan sponsors
• healthcare headlines

Mentioned in this episode

Organizations: CVS Caremark, FTC

More episodes of HR Benecast

• Episode 64 - How Bath & Body Works Approaches Open Enrollment for a Large Workforce · July 10, 2026 · 16 min
• Ep. 5 - Claim Adjudication and Reconciliation: Key Concepts Plan Sponsors Should Know · July 1, 2026 · 8 min
• Episode 63 - Zerigo Health and At-Home Phototherapy: Better Chronic Skin Condition Outcomes at a Lower Cost · June 16, 2026 · 28 min
• Ep. 5 - TrumpRx Expansion, FTC Pressure and the Growing Push for PBM Transparency · May 21, 2026 · 16 min
• Episode 62 - A Conversation with the 2026 Employers Health Excellence in Benefits Award Winner · May 12, 2026 · 19 min
• Episode 61 - GLP-1s, Biosimilars and Pharmacy Spend: Insights from Employers Health's Book of Business · April 23, 2026 · 32 min

Explore listener stats, chart rankings, contacts and more on the HR Benecast podcast page.